Science Publications

Sign Up
Sign In
Submit
Current Research in Public Health
Cite This Article Share Download PDF XML
  1. Home
  2. Journals
  3. Current Research in Public Health
  4. Archive
  5. Volume 1, Issue 1, 2022
  6. Article
Review Article Open Access September 01, 2022

Dynamics of Pharmaceutical Drugs Serialization

Naveen Rajora 1
1
Cognizant Technology Solutions, New Jersey, United States
Publihed in: Current Research in Public Health (Volume 1, Issue 1, 2022)
Page(s): 43-49
DOI: 10.31586/ujpp.2022.396
Received
July 02, 2022
Revised
August 22, 2022
Accepted
August 30, 2022
Published
September 01, 2022
Keywords
History of Pharmaceutical Industry; Pharmaceutical Barcode; Pharmaceutical Serialization; Digital Drug traceability
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2022. Published by Scientific Publications
Article metrics
Views
1060
Downloads
227

Cite This Article

APA Style
Rajora, N. (2022). Dynamics of Pharmaceutical Drugs Serialization. Current Research in Public Health, 1(1), 43-49. https://doi.org/10.31586/ujpp.2022.396
ACS Style
Rajora, N. Dynamics of Pharmaceutical Drugs Serialization. Current Research in Public Health 2022 1(1), 43-49. https://doi.org/10.31586/ujpp.2022.396
Chicago/Turabian Style
Rajora, Naveen. 2022. "Dynamics of Pharmaceutical Drugs Serialization". Current Research in Public Health 1, no. 1: 43-49. https://doi.org/10.31586/ujpp.2022.396
AMA Style
Rajora N. Dynamics of Pharmaceutical Drugs Serialization. Current Research in Public Health. 2022; 1(1):43-49. https://doi.org/10.31586/ujpp.2022.396 
@Article{crph396,
AUTHOR = {Rajora, Naveen},
TITLE = {Dynamics of Pharmaceutical Drugs Serialization},
JOURNAL = {Current Research in Public Health},
VOLUME = {1},
YEAR = {2022},
NUMBER = {1},
PAGES = {43-49},
URL = {https://www.scipublications.com/journal/index.php/UJPP/article/view/396},
ISSN = {2831-5162},
DOI = {10.31586/ujpp.2022.396},
ABSTRACT = {The healthcare access is fundamental rights for every human being. It is Governments responsibility to provide good healthcare services and infrastructure to its citizen. Since last few decades, Government and healthcare industries are struggling to minimize the adverse events impacting people health due to fake medicine. The world health organization also predicted that 4 out of 10 medicines in developing and poor countries are either fake or potentially adulterated. Counterfeit drugs cost billions of dollars deficit to world economy and reduce research and development (R&D) funds allocation from organizations. Stopping counterfeit medicine into supply chain is main challenge for Government and regulatory authorities. The Government and regulatory authorities are now making stringent guidelines to prohibit criminals and counterfeiters to supply fake medicine in markets. Healthcare industry need stringent regulations and secure technologies provide sage and authentic drugs to patients. The FDA has published the 10 years roadmap to implement the drug traceability in United States. The Healthcare Distribution Alliance (HDA) has also mandated to print several barcodes and human readable data in product packaging hierarchy. The FDA is participating in pilot project with leading pharmaceutical drug manufacturer and wholesales to use blockchain technology in interoperable digital network for securing digital traceability data transfer between authorized trading partners.},
}
%0 Journal Article
%A Rajora, Naveen
%D 2022
%J Current Research in Public Health

%@ 2831-5162
%V 1
%N 1
%P 43-49

%T Dynamics of Pharmaceutical Drugs Serialization
%M doi:10.31586/ujpp.2022.396
%U https://www.scipublications.com/journal/index.php/UJPP/article/view/396

TY  - JOUR
AU  - Rajora, Naveen
TI  - Dynamics of Pharmaceutical Drugs Serialization
T2  - Current Research in Public Health
PY  - 2022
VL  - 1
IS  - 1
SN  - 2831-5162
SP  - 43
EP  - 49
UR  - https://www.scipublications.com/journal/index.php/UJPP/article/view/396
AB  - The healthcare access is fundamental rights for every human being. It is Governments responsibility to provide good healthcare services and infrastructure to its citizen. Since last few decades, Government and healthcare industries are struggling to minimize the adverse events impacting people health due to fake medicine. The world health organization also predicted that 4 out of 10 medicines in developing and poor countries are either fake or potentially adulterated. Counterfeit drugs cost billions of dollars deficit to world economy and reduce research and development (R&D) funds allocation from organizations. Stopping counterfeit medicine into supply chain is main challenge for Government and regulatory authorities. The Government and regulatory authorities are now making stringent guidelines to prohibit criminals and counterfeiters to supply fake medicine in markets. Healthcare industry need stringent regulations and secure technologies provide sage and authentic drugs to patients. The FDA has published the 10 years roadmap to implement the drug traceability in United States. The Healthcare Distribution Alliance (HDA) has also mandated to print several barcodes and human readable data in product packaging hierarchy. The FDA is participating in pilot project with leading pharmaceutical drug manufacturer and wholesales to use blockchain technology in interoperable digital network for securing digital traceability data transfer between authorized trading partners.
DO  - Dynamics of Pharmaceutical Drugs Serialization
TI  - 10.31586/ujpp.2022.396
ER  -